Cannara Biotech Inc opened trading today at $0.72 and closed at $0.73. prices ranged from a low of $0.72 to a high of $0.73.
Shares advanced 1.39% from the previous day's close of $0.72.
Today across North America, the TSX Composite closed -1.20% at 21698.11, the S&P 500 closed 0.85% at 5421.03, the Dow Jones Industrial Average closed -0.09% at 38712.21 and the Nasdaq Composite closed 1.53% at 17608.44.
Cannara Biotech Inc traded under LOVE on the Toronto Venture Exchange (TSX-V).
A total of 5,888 shares was traded during the last trading day, with total trades of 10, with an average volume of 8,609 over 5 days.
The TSX-V overall saw 1,600 price advancers against 3,644 declines and 110 unchanged.
During the prior 52 weeks, LOVE.VN has traded as high as $1.14 (August 04,2023) and low as $0.67 (May 09,2024). Moreover, in the last 12 months, Cannara Biotech Inc's shares have dipped -24.74%, while they have reduced -12.05% year-to-date.
Following today's trading, Cannara Biotech Inc has a market capitalization of $64.81 million on a float of 90,019 shares outstanding. Its annual EPS is $0.07.
Cannara Biotech Inc is a TSX Drug Specialty & Generic company headquartered in Vancouver, CAN.
Based on 0.00 analysts, Cannara Biotech Inc gets an average recommendation of "Strong Sell" according to Zacks. Currently, there are for the stock.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..